AQR Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
11,968
-163
| -1% | -$22.4K | ﹤0.01% | 1904 |
|
|
2025
Q1 | $2.19M | Buy |
12,131
+2,792
| +30% | +$503K | ﹤0.01% | 1563 |
|
|
2024
Q4 | $1.46M | Buy |
9,339
+989
| +12% | +$155K | ﹤0.01% | 1688 |
|
|
2024
Q3 | $1.52M | Buy |
8,350
+763
| +10% | +$139K | ﹤0.01% | 1629 |
|
|
2024
Q2 | $1.39M | Buy |
7,587
+1,551
| +26% | +$285K | ﹤0.01% | 1614 |
|
|
2024
Q1 | $1.07M | Buy |
6,036
+1,734
| +40% | +$309K | ﹤0.01% | 1658 |
|
|
2023
Q4 | $534K | Buy |
4,302
+288
| +7% | +$35.7K | ﹤0.01% | 1852 |
|
|
2023
Q3 | $466K | Sell |
4,014
-437
| -10% | -$50.7K | ﹤0.01% | 1871 |
|
|
2023
Q2 | $523K | Buy |
4,451
+507
| +13% | +$59.5K | ﹤0.01% | 1774 |
|
|
2023
Q1 | $316K | Buy |
3,944
+236
| +6% | +$18.9K | ﹤0.01% | 1928 |
|
|
2022
Q4 | $294K | Buy |
+3,708
| New | +$294K | ﹤0.01% | 1978 |
|
|
2020
Q3 | – | Sell |
-8,377
| Closed | -$347K | – | 2227 |
|
|
2020
Q2 | $347K | Sell |
8,377
-3,920
| -32% | -$162K | ﹤0.01% | 1851 |
|
|
2020
Q1 | $532K | Buy |
12,297
+2,448
| +25% | +$106K | ﹤0.01% | 1559 |
|
|
2019
Q4 | $545K | Sell |
9,849
-681
| -6% | -$37.7K | ﹤0.01% | 1727 |
|
|
2019
Q3 | $366K | Buy |
10,530
+1,458
| +16% | +$50.7K | ﹤0.01% | 1854 |
|
|
2019
Q2 | $365K | Buy |
+9,072
| New | +$365K | ﹤0.01% | 1813 |
|